2-(3-Bromophenyl)-1,3-dioxolane>97.0%(GC)5g

4-Chloro-1H-pyrrolo[3,2-c]pyridine, 95.0%, 250mg

1-(1-piperidinylsulfonyl)-1,4-diazepane, 95.0%, 1g

2-(((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol, 95.0%, 5g

1,1,3,3-Tetramethyl-1,3-diethoxydisiloxane, 95%, 25g

(2E)-3-(dimethylamino)-1-(3-thienyl)prop-2-en-1-one, 1g

ETHYL 4-HYDROXY-1-((PIVALOYLOXY)METHYL)CYCLOHEXANECARBOXYLATE, 95.0%, 250mg

4,6-Dichloro-2-(difluoromethyl)pyrimidine, 97%, 100g

Accessories exchange block for reaction vessels, Gesch. for, 35 reaction vials 2.0 ml, 1 piece

(3-(Aminomethyl)phenyl)methanol hydrochloride, 95.0%, 10g

4-Bromo-1-ethynyl-2-fluorobenzene, 95+%, 1g

5-Chloro-2-ethynylbenzaldehyde, 97%, 1g

4-(1 H -Benzoimidazol-2-yl)-benzoic acid, 95.0%, 1g